Skip to main content
Top
Published in: BMC Nephrology 1/2022

Open Access 01-12-2022 | Hematuria | Case report

A case report of atypical anti-glomerular basement membrane disease

Authors: Ryo Tamura, Toshiki Doi, Shuma Hirashio, Kensuke Sasaki, Yukinari Masuda, Akira Shimizu, Takao Masaki

Published in: BMC Nephrology | Issue 1/2022

Login to get access

Abstract

Background

Anti-glomerular basement membrane (anti-GBM) disease is characterized by crescentic necrotizing glomerulonephritis, with linear deposits of immunoglobulin G (IgG) in the GBM. Classic anti-GBM disease is clinically associated with rapidly progressive glomerulonephritis with or without pulmonary hemorrhage. Some patients have a better renal prognosis and milder symptoms than those with classic anti-GBM disease, which is termed atypical anti-GBM disease.

Case presentation

A 43-year-old Japanese woman was admitted to our hospital complaining of hematuria that had persisted for more than one month. Serological examination revealed negativity for anti-nuclear, anti-neutrophilic cytoplasmic, and anti-GBM antibodies. However, renal biopsy showed cellular crescents. Immunofluorescence revealed strong diffuse linear capillary loop staining for IgG. An indirect immunofluorescence antibody method was performed by applying the patient serum to normal kidney tissue to confirm the presence of autoantibodies binding to the GBM. Using this method, anti-GBM antibodies were detected. The patient was treated with high-dose steroids, cyclophosphamide, and plasma exchange. Aggressive treatment resolved proteinuria and hematuria and improved renal function.

Conclusions

Renal biopsy is crucial in the diagnosis of anti-GBM disease, especially when serological tests are negative. Accurately identifying the presence of anti-GBM disease is important to initiate optimal treatment.
Literature
1.
go back to reference Fischer EG, Lager DJ. Anti-glomerular basement membrane glomerulonephritis: a morphologic study of 80 cases. Am J Clin Pathol. 2006;125(3):445–50.CrossRefPubMed Fischer EG, Lager DJ. Anti-glomerular basement membrane glomerulonephritis: a morphologic study of 80 cases. Am J Clin Pathol. 2006;125(3):445–50.CrossRefPubMed
2.
go back to reference Saus J, Wieslander J, Langeveld JP, Quinones S, Hudson BG. Identification of the Goodpasture antigen as the alpha 3(IV) chain of collagen IV. J Biol Chem. 1988;263(26):13374–80.CrossRefPubMed Saus J, Wieslander J, Langeveld JP, Quinones S, Hudson BG. Identification of the Goodpasture antigen as the alpha 3(IV) chain of collagen IV. J Biol Chem. 1988;263(26):13374–80.CrossRefPubMed
3.
go back to reference Hellmark T, Johansson C, Wieslander J. Characterization of anti-GBM antibodies involved in Goodpasture's syndrome. Kidney Int. 1994;46(3):823–9.CrossRefPubMed Hellmark T, Johansson C, Wieslander J. Characterization of anti-GBM antibodies involved in Goodpasture's syndrome. Kidney Int. 1994;46(3):823–9.CrossRefPubMed
4.
go back to reference Koyama A, Yamagata K, Makino H, Arimura Y, Wada T, Nitta K, et al. A nationwide survey of rapidly progressive glomerulonephritis in Japan: etiology, prognosis and treatment diversity. Clin Exp Nephrol. 2009;13(6):633–50.CrossRefPubMed Koyama A, Yamagata K, Makino H, Arimura Y, Wada T, Nitta K, et al. A nationwide survey of rapidly progressive glomerulonephritis in Japan: etiology, prognosis and treatment diversity. Clin Exp Nephrol. 2009;13(6):633–50.CrossRefPubMed
5.
6.
go back to reference Benz K, Amann K, Dittrich K, Hugo C, Schnur K, Dötsch J. Patient with antibody-negative relapse of Goodpasture syndrome. Clin Nephrol. 2007;67(4):240–4.CrossRefPubMed Benz K, Amann K, Dittrich K, Hugo C, Schnur K, Dötsch J. Patient with antibody-negative relapse of Goodpasture syndrome. Clin Nephrol. 2007;67(4):240–4.CrossRefPubMed
7.
go back to reference Kussman A, Gohara A. Serum antibody-negative Goodpasture syndrome with delta granule pool storage deficiency and eosinophilia. Clin Kidney J. 2012;5(6):572–5.CrossRefPubMedPubMedCentral Kussman A, Gohara A. Serum antibody-negative Goodpasture syndrome with delta granule pool storage deficiency and eosinophilia. Clin Kidney J. 2012;5(6):572–5.CrossRefPubMedPubMedCentral
8.
go back to reference Nasr SH, Collins AB, Alexander MP, Schraith DF, Herrera Hernandez L, Fidler ME, et al. The clinicopathologic characteristics and outcome of atypical anti-glomerular basement membrane nephritis. Kidney Int. 2016;89(4):897–908.CrossRefPubMed Nasr SH, Collins AB, Alexander MP, Schraith DF, Herrera Hernandez L, Fidler ME, et al. The clinicopathologic characteristics and outcome of atypical anti-glomerular basement membrane nephritis. Kidney Int. 2016;89(4):897–908.CrossRefPubMed
9.
go back to reference Liang D, Liang S, Xu F, Zhang M, Li X, Tu Y, et al. Clinicopathological features and outcome of antibody-negative anti-glomerular basement membrane disease. J Clin Pathol. 2019;72(1):31–7.CrossRefPubMed Liang D, Liang S, Xu F, Zhang M, Li X, Tu Y, et al. Clinicopathological features and outcome of antibody-negative anti-glomerular basement membrane disease. J Clin Pathol. 2019;72(1):31–7.CrossRefPubMed
10.
go back to reference Shen CR, Jia XY, Cui Z, Yu XJ, Zhao MH. Clinical-Pathological Features and Outcome of Atypical Anti-glomerular Basement Membrane Disease in a Large Single Cohort. Front Immunol. 2020;11:2035.CrossRefPubMedPubMedCentral Shen CR, Jia XY, Cui Z, Yu XJ, Zhao MH. Clinical-Pathological Features and Outcome of Atypical Anti-glomerular Basement Membrane Disease in a Large Single Cohort. Front Immunol. 2020;11:2035.CrossRefPubMedPubMedCentral
11.
go back to reference Gulati K, McAdoo SP. Anti-Glomerular Basement Membrane Disease. Rheum Dis Clin North Am. 2018;44(4):651–73.CrossRefPubMed Gulati K, McAdoo SP. Anti-Glomerular Basement Membrane Disease. Rheum Dis Clin North Am. 2018;44(4):651–73.CrossRefPubMed
12.
go back to reference Levy JB, Turner AN, Rees AJ, Pusey CD. Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med. 2001;134(11):1033–42.CrossRefPubMed Levy JB, Turner AN, Rees AJ, Pusey CD. Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med. 2001;134(11):1033–42.CrossRefPubMed
13.
go back to reference Cui Z, Zhao J, Jia XY, Zhu SN, Jin QZ, Cheng XY, et al. Anti-glomerular basement membrane disease: outcomes of different therapeutic regimens in a large single-center Chinese cohort study. Medicine (Baltimore). 2011;90(5):303–11.CrossRefPubMed Cui Z, Zhao J, Jia XY, Zhu SN, Jin QZ, Cheng XY, et al. Anti-glomerular basement membrane disease: outcomes of different therapeutic regimens in a large single-center Chinese cohort study. Medicine (Baltimore). 2011;90(5):303–11.CrossRefPubMed
14.
go back to reference Lerner RA, Glassock RJ, Dixon FJ. The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Exp Med. 1967;126(6):989–1004.CrossRefPubMedPubMedCentral Lerner RA, Glassock RJ, Dixon FJ. The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Exp Med. 1967;126(6):989–1004.CrossRefPubMedPubMedCentral
15.
go back to reference Netzer KO, Leinonen A, Boutaud A, Borza DB, Todd P, Gunwar S, et al. The goodpasture autoantigen. Mapping the major conformational epitope(s) of alpha3(IV) collagen to residues 17–31 and 127–141 of the NC1 domain. J Biol Chem. 1999;274(16):11267–74.CrossRefPubMed Netzer KO, Leinonen A, Boutaud A, Borza DB, Todd P, Gunwar S, et al. The goodpasture autoantigen. Mapping the major conformational epitope(s) of alpha3(IV) collagen to residues 17–31 and 127–141 of the NC1 domain. J Biol Chem. 1999;274(16):11267–74.CrossRefPubMed
16.
go back to reference Borza DB, Netzer KO, Leinonen A, Todd P, Cervera J, Saus J, et al. The goodpasture autoantigen. Identification of multiple cryptic epitopes on the NC1 domain of the alpha3(IV) collagen chain. J Biol Chem. 2000;275(8):6030–7.CrossRefPubMed Borza DB, Netzer KO, Leinonen A, Todd P, Cervera J, Saus J, et al. The goodpasture autoantigen. Identification of multiple cryptic epitopes on the NC1 domain of the alpha3(IV) collagen chain. J Biol Chem. 2000;275(8):6030–7.CrossRefPubMed
17.
go back to reference Pedchenko V, Bondar O, Fogo AB, Vanacore R, Voziyan P, Kitching AR, et al. Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis. N Engl J Med. 2010;363(4):343–54.CrossRefPubMedPubMedCentral Pedchenko V, Bondar O, Fogo AB, Vanacore R, Voziyan P, Kitching AR, et al. Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis. N Engl J Med. 2010;363(4):343–54.CrossRefPubMedPubMedCentral
18.
go back to reference Dammacco F, Battaglia S, Gesualdo L, Racanelli V. Goodpasture's disease: a report of ten cases and a review of the literature. Autoimmun Rev. 2013;12(11):1101–8.CrossRefPubMed Dammacco F, Battaglia S, Gesualdo L, Racanelli V. Goodpasture's disease: a report of ten cases and a review of the literature. Autoimmun Rev. 2013;12(11):1101–8.CrossRefPubMed
19.
go back to reference Yang R, Hellmark T, Zhao J, Cui Z, Segelmark M, Zhao MH, et al. Levels of epitope-specific autoantibodies correlate with renal damage in anti-GBM disease. Nephrol Dial Transplant. 2009;24(6):1838–44.CrossRefPubMed Yang R, Hellmark T, Zhao J, Cui Z, Segelmark M, Zhao MH, et al. Levels of epitope-specific autoantibodies correlate with renal damage in anti-GBM disease. Nephrol Dial Transplant. 2009;24(6):1838–44.CrossRefPubMed
20.
go back to reference Olaru F, Wang XP, Luo W, Ge L, Miner JH, Kleinau S, et al. Proteolysis breaks tolerance toward intact α345(IV) collagen, eliciting novel anti-glomerular basement membrane autoantibodies specific for α345NC1 hexamers. J Immunol. 2013;190(4):1424–32.CrossRefPubMed Olaru F, Wang XP, Luo W, Ge L, Miner JH, Kleinau S, et al. Proteolysis breaks tolerance toward intact α345(IV) collagen, eliciting novel anti-glomerular basement membrane autoantibodies specific for α345NC1 hexamers. J Immunol. 2013;190(4):1424–32.CrossRefPubMed
21.
go back to reference Salama AD, Dougan T, Levy JB, Cook HT, Morgan SH, Naudeer S, et al. Goodpasture's disease in the absence of circulating anti-glomerular basement membrane antibodies as detected by standard techniques. Am J Kidney Dis. 2002;39(6):1162–7.CrossRefPubMed Salama AD, Dougan T, Levy JB, Cook HT, Morgan SH, Naudeer S, et al. Goodpasture's disease in the absence of circulating anti-glomerular basement membrane antibodies as detected by standard techniques. Am J Kidney Dis. 2002;39(6):1162–7.CrossRefPubMed
22.
go back to reference Jia XY, Qu Z, Cui Z, Yang R, Zhao J, Zhao MH. Circulating anti-glomerular basement membrane autoantibodies against α3(IV)NC1 undetectable by commercially available enzyme-linked immunosorbent assays. Nephrology (Carlton). 2012;17(2):160–6.CrossRefPubMed Jia XY, Qu Z, Cui Z, Yang R, Zhao J, Zhao MH. Circulating anti-glomerular basement membrane autoantibodies against α3(IV)NC1 undetectable by commercially available enzyme-linked immunosorbent assays. Nephrology (Carlton). 2012;17(2):160–6.CrossRefPubMed
23.
go back to reference Mahler M, Radice A, Sinico RA, Damoiseaux J, Seaman A, Buckmelter K, et al. Performance evaluation of a novel chemiluminescence assay for detection of anti-GBM antibodies: an international multicenter study. Nephrol Dial Transplant. 2012;27(1):243–52.CrossRefPubMed Mahler M, Radice A, Sinico RA, Damoiseaux J, Seaman A, Buckmelter K, et al. Performance evaluation of a novel chemiluminescence assay for detection of anti-GBM antibodies: an international multicenter study. Nephrol Dial Transplant. 2012;27(1):243–52.CrossRefPubMed
Metadata
Title
A case report of atypical anti-glomerular basement membrane disease
Authors
Ryo Tamura
Toshiki Doi
Shuma Hirashio
Kensuke Sasaki
Yukinari Masuda
Akira Shimizu
Takao Masaki
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2022
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-022-03007-y

Other articles of this Issue 1/2022

BMC Nephrology 1/2022 Go to the issue